Genetic perturbation of PU.1 binding and chromatin looping at neutrophil enhancers associates with autoimmune disease.
Stephen WattLouella VasquezKlaudia WalterAlice L MannKousik KunduLu ChenYing SimsSimone EckerFrances BurdenSamantha FarrowBen FarrValentina IotchkovaHeather EldingDaniel MeadManuel TardaguilaHannes PonstinglDavid RichardsonAvik DattaPaul FlicekLaura ClarkeKate DownesTomi PastinenPeter FraserMattia FrontiniBiola-Maria JavierreMikhail SpivakovNicole SoranzoPublished in: Nature communications (2021)
Neutrophils play fundamental roles in innate immune response, shape adaptive immunity, and are a potentially causal cell type underpinning genetic associations with immune system traits and diseases. Here, we profile the binding of myeloid master regulator PU.1 in primary neutrophils across nearly a hundred volunteers. We show that variants associated with differential PU.1 binding underlie genetically-driven differences in cell count and susceptibility to autoimmune and inflammatory diseases. We integrate these results with other multi-individual genomic readouts, revealing coordinated effects of PU.1 binding variants on the local chromatin state, enhancer-promoter contacts and downstream gene expression, and providing a functional interpretation for 27 genes underlying immune traits. Collectively, these results demonstrate the functional role of PU.1 and its target enhancers in neutrophil transcriptional control and immune disease susceptibility.